Belite Bio Ownership | Who Owns Belite Bio?

Belite Bio Ownership Summary

Belite Bio is owned by 3.07% institutional investors, 46.78% insiders, and 50.14% retail investors. Ra capital management is the largest institutional shareholder, holding 2.69% of BLTE shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 0.97% of its assets in Belite Bio shares.

BLTE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Belite Bio	3.07%	46.78%	50.14%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	875.00K	2.69%	$64.75M
Ubs group	768.36K	2.29%	$122.51M
Rtw investments, lp	312.50K	0.96%	$23.13M
Vestal point capital, lp	312.50K	0.96%	$23.13M
Eventide asset management	195.31K	0.60%	$14.45M
Marshall wace, llp	187.50K	0.58%	$13.88M
Perceptive advisors	49.79K	0.15%	$3.68M
Goldman sachs group	44.60K	0.13%	$7.13M
Soleus capital management	40.35K	0.12%	$6.46M
Td asset management	33.41K	0.10%	$5.33M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vestal point capital, lp	312.50K	1.04%	$23.13M
Ra capital management	875.00K	0.80%	$64.75M
Rtw investments, lp	312.50K	0.28%	$23.13M
Soleus capital management	40.35K	0.24%	$6.46M
Eventide asset management	195.31K	0.24%	$14.45M
High net worth advisory group	3.50K	0.13%	$558.04K
Yeomans consulting group	2.40K	0.11%	$383.74K
Perceptive advisors	49.79K	0.11%	$3.68M
Arrowpoint investment partners (singapore) pte.	3.05K	0.07%	$487.72K
Convergence financial	2.97K	0.05%	$473.22K

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	875.00K	0.80%	875.00K
Ubs group	768.36K	0.02%	639.61K
Vestal point capital, lp	312.50K	1.04%	312.50K
Rtw investments, lp	312.50K	0.28%	312.50K
Eventide asset management	195.31K	0.24%	195.31K

Top Sellers

Holder	Shares	% Assets	Change
Soleus capital management	40.35K	0.24%	-169.65K
Armistice capital	-	-	-167.93K
Alyeska investment group	-	-	-83.62K
Western standard	-	-	-60.03K
Jane street group	12.22K	0.00%	-20.10K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	875.00K	0.80%	875.00K	$64.75M
Rtw investments, lp	312.50K	0.28%	312.50K	$23.13M
Vestal point capital, lp	312.50K	1.04%	312.50K	$23.13M
Eventide asset management	195.31K	0.24%	195.31K	$14.45M
Perceptive advisors	49.79K	0.11%	49.79K	$3.68M

Sold Out

Holder	Change
Pnc financial services group	-8.00
Quantbot technologies lp	-11.00
Tower research capital llc (trc)	-14.00
China universal asset management	-500.00
Persistent asset partners	-673.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	37	8.82%	1,020,646	-55.40%	3	6.23%	27	-3.57%	8	60.00%
Sep 30, 2025	33	106.25%	2,288,468	3161.04%	7	15139.46%	28	180.00%	4	-20.00%
Jun 30, 2025	18	-	78,139	-47.79%	-	105.93%	12	-	5	-
Mar 31, 2025	18	-14.29%	149,657	-47.01%	-	56.18%	12	-14.29%	5	-
Dec 31, 2024	21	40.00%	282,406	258.84%	-	1398.99%	14	27.27%	5	150.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Eventide Healthcare & Life Sciences I	383.09K	0.97%	187.78K
MEDICAL BioHealth EUR Acc	130.05K	0.33%	-133.00
HBM Healthcare Investments AG Ord	90.00K	0.26%	90.00K
Alger Small Cap Focus Composite	57.15K	0.14%	5.50K
Alger Small Cap Focus I	57.15K	0.14%	5.50K
apo Medical Opportunities R	23.16K	0.06%	-
BrighthouseI Morgan Stanley Discovery B	15.91K	0.04%	15.91K
RIM Global Bioscience EUR	14.60K	0.04%	-2.00K
SPDR® Portfolio Emerging Markets ETF	10.93K	0.03%	-
State Street® SPDR® Portfolio EM ETF	12.46K	0.03%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 07, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$463.83
May 07, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$1.40K
May 07, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$34.45K
May 07, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$65.73K
May 06, 2026	MATA NATHAN L.	Chief Scientific Officer	Sell	$37.06K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	112
2026 Q1	-	-

BLTE Ownership FAQ

Who Owns Belite Bio?

Belite Bio shareholders are primarily institutional investors at 3.07%, followed by 46.78% insiders and 50.15% retail investors. The average institutional ownership in Belite Bio's industry, Biotech Stocks , is 382.13%, which Belite Bio falls below.

Who owns the most shares of Belite Bio?

Belite Bio’s largest shareholders are Ra capital management (875K shares, 2.69%), Ubs group (768.36K shares, 2.29%), and Rtw investments, lp (312.5K shares, 0.96%). Together, they hold 5.94% of Belite Bio’s total shares outstanding.

Does Blackrock own Belite Bio?

BlackRock is not among the top 10 institutional shareholders of Belite Bio.

Who is Belite Bio’s biggest shareholder by percentage of total assets invested?

Vestal point capital, lp is Belite Bio’s biggest shareholder by percentage of total assets invested, with 1.04% of its assets in 312.5K Belite Bio shares, valued at 23.12M$.

Who is the top mutual fund holder of Belite Bio shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Belite Bio shares, with 0.97% of its total shares outstanding invested in 383.09K Belite Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools